FDA approves drug that slows early Alzheimer's disease

Name: FDA approves drug that slows early Alzheimer's disease
Uploaded: 2023-07-07T14:49:00-0500
Duration: 1 min 52 s
Description: In a clinical trial with 1,00 participants, researchers found Lecanemab can slow cognitive decline in Alzheimer's patients by 27%, effectively delaying the disease by about five months. a href=“https://www.cbsnews.com/texas/news/alzheimers-disease-drug-medication-fda-approves-lecanemab-leqembi/”Click here for more./a

In a clinical trial with 1,00 participants, researchers found Lecanemab can slow cognitive decline in Alzheimer's patients by 27%, effectively delaying the disease by about five months. a href=“https://www.cbsnews.com/texas/news/alzheimers-disease-drug-medication-fda-approves-lecanemab-leqembi/”Click here for more./a